Westchester Capital Management (New York)’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-110,613
Closed -$1.31M 229
2025
Q1
$1.31M Buy
+110,613
New +$1.3M 0.07% 115
2024
Q4
Sell
-1,611,362
Closed -$18.5M 186
2024
Q3
$18.5M Buy
1,611,362
+359,991
+29% +$4.09M 0.79% 25
2024
Q2
$14.1M Hold
1,251,371
0.53% 34
2024
Q1
$13.9M Buy
1,251,371
+174,811
+16% +$1.93M 0.51% 33
2023
Q4
$11.8M Sell
1,076,560
-72,789
-6% -$792K 0.41% 40
2023
Q3
$12.4M Buy
1,149,349
+27,367
+2% +$294K 0.36% 51
2023
Q2
$12M Buy
1,121,982
+250,000
+29% +$2.64M 0.38% 59
2023
Q1
$9.15M Buy
+871,982
New +$9.06M 0.28% 109

Other funds holding RENE

Westchester Capital Management (New York)'s RENE Position: Q2 2025 in Review

Westchester Capital Management (New York) sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 110,613 shares — an estimated $1.31M sold.

Westchester Capital Management (New York) first reported a position in RENE in Q1 2023 and held it in 8 quarters. The position peaked at $18.5M in Q3 2024. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Westchester Capital Management (New York) reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 110,613 Cartesian Growth Corp II shares in Q2 2025, an estimated $1.31M.
  • Westchester Capital Management (New York) first reported a position in Cartesian Growth Corp II in Q1 2023 and held it in 8 quarters.
  • Westchester Capital Management (New York)'s Cartesian Growth Corp II position peaked at $18.5M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2025, filed 14 Aug 2025.